<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02877537</url>
  </required_header>
  <id_info>
    <org_study_id>2007-002822-31</org_study_id>
    <nct_id>NCT02877537</nct_id>
  </id_info>
  <brief_title>Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis</brief_title>
  <acronym>SALBUTAMOL</acronym>
  <official_title>Measurements of Change of Respiratory Admittance Induced by Salbutamol for Pediatric Asthma Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to characterize the change of respiratory admittance induced by salbutamol
      inhalation in children and young adults. A variation threshold will be fixed to distinguish
      asthmatic and healthy subjects.

      This project could allow a better identification of asthmatic individuals needing a
      treatment, a reduction of morbidity of asthma, a reduction of unnecessary treatments
      administered in individuals with respiratory but not asthmatic symptoms, a better
      comprehension of bronchial hyperreactivity and its role in asthmatic disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilatory mechanical impedance</measure>
    <time_frame>day 0</time_frame>
    <description>Measured with Forced oscillation technique. 2 measures at basal status at 10 min interval for reproducibility and after 10 min broncodilation with salbutamol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoracic gas volume</measure>
    <time_frame>day 0</time_frame>
    <description>Measured with Plethysmography.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">177</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Asthma child</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control adult</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control child</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Salbutamol</intervention_name>
    <description>bronchodilation obtained with 2 inhalations of salbutamol (100 µg per dose) with inhalation chamber</description>
    <arm_group_label>Asthma child</arm_group_label>
    <arm_group_label>Control adult</arm_group_label>
    <arm_group_label>Control child</arm_group_label>
    <other_name>Ventoline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Forced oscillation technique</intervention_name>
    <description>before and after bronchodilation</description>
    <arm_group_label>Asthma child</arm_group_label>
    <arm_group_label>Control adult</arm_group_label>
    <arm_group_label>Control child</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Plethysmography</intervention_name>
    <arm_group_label>Asthma child</arm_group_label>
    <arm_group_label>Control adult</arm_group_label>
    <arm_group_label>Control child</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Asthmatic children group:

          -  Several episodes of paroxysmal wheezes, spontaneous or after exercise, without
             bronchial-pulmonary infection

          -  Absence of bronchodilator taking during last 12 hours

          -  Absence of reported intolerance to adrenergic substances

          -  Parental authorization and consent of child to participate to the study

        Control children group:

        - Parental authorization and consent of child to participate to the study

        Control adult group:

        - Consent to participate to the study

        Exclusion Criteria:

        Control children and adult groups:

          -  At least 2 episodes of wheezes during breathing

          -  Several wheezes, abnormal breathlessness, cough during physical exercise

          -  Asthma diagnosed by family doctor

          -  Administration of drugs to treat asthma

          -  Eczema or food allergy at inclusion

          -  Episode of cough for longer than 6 weeks, without bronchial infection

          -  Bronchitis, throat infection, rhino-pharyngitis during last 15 days

          -  Paleness or cyanosis with loss of consciousness when the child was a baby or during an
             exercise
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François MARCHAL</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nancy - Hôpital BRABOIS Enfants - Explorations fonctionnelles pédiatriques</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nancy - Hôpital BRABOIS Enfants - Explorations fonctionnelles pédiatriques</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>August 19, 2016</last_update_submitted>
  <last_update_submitted_qc>August 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuterol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

